# Addex Therapeutics Ltd.: Form 6-K, filed Nov 22, 2024

- Company: [Addex Therapeutics Ltd.](/companies/adxn.md) (CIK 1574232)
- Form: 6-K
- Filed: 2024-11-22
- Accepted by EDGAR: Nov 22, 2024, 06:00 ET
- Period: 2024-11-22
- Accession: 0001104659-24-121730
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1574232/000110465924121730/tm2429141d1_6k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574232/000110465924121730/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574232/000110465924121730/tm2429141d1_6k.htm

Filed Nov 22, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-121730. Last ingested by Listed: Nov 14, 2026, 18:51 ET. No prices; not investment advice.
